Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Opinions/ J3 outcome almost a moot point

RE: Opinions/ J3 outcome almost a moot point

posted on Jun 23, 2006 07:26PM
J3 will cave before year-end.
Share
New Message
Please login to post a reply